Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases
Biomolecules · 12.06.2025 · 15 (6) · 858
DOI: 10.3390/biom15060858 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 12.06.2025. Verfasst von Ning Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Henan Institute of Technology, Xinxiang 453003, China. Hauptthemen laut MEDLINE: Troponin I, Cardiovascular Diseases, Biosensing Techniques. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Scientific and Technological Project of Henan Province, Key Scientific and Technological Project of Henan Province.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality rates globally, presenting a severe threat to human health and life. Acute myocardial infarction (AMI) is one of the most common and extremely severe disorders within CVDs, causing an estimated 17.5 million deaths each year. Cardiac troponin I (cTnI) is considered a biomarker for myocardial infarction and a “gold standard” method for diagnosing AMI due to its high specificity and sensitivity. The ability to rapidly detect cTnI with high sensitivity is critical throughout the diagnosis and treatment process of AMI. It is a necessary precursor for doctors to quickly assess the disease and initiate subsequent therapies. This work comprehensively explores various techniques for the analysis and detection of cTnI. We systematically review current cutting-edge technologies used for cTnI detection. According to optical, electrical, and intelligent technology dimensions, this study meticulously classifies and elaborates on the research progress of related sensors. Based on current research findings and technological development trends, we further project the future research directions and application prospects of cTnI sensors. This is geared towards providing valuable references for the further development of this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Henan Institute of Technology, Xinxiang 453003, China.
- School of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.
Förderung
- the Key Scientific and Technological Project of Henan Province
- Key Scientific and Technological Project of Henan Province
Zitieren
APA
Zhang, N., Wang, Y., Li, F., Zhu, Y., Fu, Z., Jia, M., Zhan, X., & Zhang, W. (2025). Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases. Biomolecules, 15(6), 858. https://doi.org/10.3390/biom15060858
Vancouver
Zhang N, Wang Y, Li F, Zhu Y, Fu Z, Jia M, et al. Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases. Biomolecules. 2025;15(6):858. doi:10.3390/biom15060858
BibTeX
@article{Zhang2025,
author = {Zhang, Ning and Wang, Yusong and Li, Fachuang and Zhu, Yuxin and Fu, Zheng and Jia, Mengda and Zhan, Xiaoran and Zhang, Wanqing},
title = {Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {6},
pages = {858},
doi = {10.3390/biom15060858}
}
EUVIMED